Results 41 to 50 of about 120,763 (113)

Repurposing Quetiapine as an Adjuvant Therapeutic Agent for Triple-Negative Breast Cancer. [PDF]

Radiat Res
He L, Joshi P, Ioannidis A, Kathiravan A, Saki M, Pajonk F.   +5 more
europepmc   +1 more source

Next-Generation Therapeutic Targets in Triple-Negative Breast Cancer. [PDF]

Eur J Breast Health
Saleem KM, Amirova MF, Rahimov JA, Musayev KN, Huseynova EE, Melikova NV.   +5 more
europepmc   +1 more source

Nanobioconjugate Trispecific Antibody Augments Antitumor Immunity of Triple Negative Breast Cancer. [PDF]

Int J Nanomedicine
Chang Q, Liu L.
europepmc   +1 more source

Pneumonitis During Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer: A Case Report. [PDF]

Cureus
Bakalis A, Bouliaris K, Psoma F, Sgantzou IK, Lambrodimou G.   +4 more
europepmc   +1 more source

Computational Design of an mRNA Vaccine Targeting LRP6 for Triple-Negative Breast Cancer Therapy. [PDF]

Cancer Rep (Hoboken)
Teimoori P, Heidari M.
europepmc   +1 more source

Integrated Network Pharmacology and Machine Learning to Reveal the Mechanisms of Schisandrin A Against Triple-Negative Breast Cancer. [PDF]

J Cell Mol Med
Xu M, Zhang Y, Mei R, Xue T, Cai H, Zhou Y, Guo J.   +6 more
europepmc   +1 more source

The role of pluripotency regulators in triple-negative breast cancer immune response. [PDF]

Front Genet
López-Santana C, Mendez-Rivera F, Bernal-Estévez DA.   +2 more
europepmc   +1 more source